Our previously derived models of the active state of the β 2 -adrenergic receptor are compared with recently published X-ray crystallographic structures of activated GPCRs (G-protein-coupled receptors). These molecular dynamics-based models using experimental data derived from biophysical experiments on activation were used to restrain the receptor to an active state that gave high enrichment for agonists in virtual screening. The β 2 -adrenergic receptor active model and X-ray structures are in good agreement over both the transmembrane region and the orthosteric binding site, although in some regions the active model is more similar to the active rhodopsin X-ray structures. The general features of the microswitches were well reproduced, but with minor differences, partly because of the unexpected X-ray results for the rotamer toggle switch. In addition, most of the interacting residues between the receptor and the G-protein were identified. This analysis of the modelling has also given important additional insight into GPCR dimerization: re-analysis of results on photoaffinity analogues of rhodopsin provided additional evidence that TM4 (transmembrane helix 4) resides at the dimer interface and that ligands such as bivalent ligands may pass between the mobile helices. A comparison, and discussion, is also carried out between the use of implicit and explicit solvent for active-state modelling.
Introduction
GPCRs (G-protein-coupled receptors) are dynamic structures, as shown by their ability to dimerize [1] , domain swap [2] [3] [4] [5] oligomerize [6, 7] activate G-proteins [8, 9] and signal via arrestin [10] . Moreover, even in the ground state they exhibit sufficient thermal motion to make crystallization difficult in the absence of thermostabilizing mutations [11] [12] [13] [14] . This inherent flexibility and the existence of multiple conformations in the signalling cycle make the modelling of the active state particularly challenging. We have addressed this task previously by using molecular dynamics simulations guided by carefully derived constraints based on biophysical and biochemical measurements [3, 15, 16] . We have a timely opportunity to assess computational approaches to modelling the GPCR active state since a number of active crystal structures have been published since the publication of our
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active model; such an analysis is important for understanding the range of validity of molecular modelling.
Molecular dynamics is well suited to studying protein dynamics. In the present paper, we assess the suitability of implicit membrane simulations [17, 18] for modelling GPCR structure and activation [15] , and in the process also gain insight into GPCR dimerization. The advantage of implicit membrane methods, as in all coarse-grain methods, is that the reduced representation may allow greater sampling, partly because the CPU requirements are less and partly because the implicit membrane and implicit solvent do not impede the dynamics as much as their explicit counterparts; as a consequence they are less likely to encounter restraining interactions.
The greater ability to sample phase space is important in modelling GPCR activation because of the complex conformational changes involved, which were initially inferred from biochemical and biophysical studies [15, 16] . The nature of these changes is now much clearer since the active GPCR crystal structures were solved, but the magnitude of the changes nevertheless varies between the different active structures as they represent different parts of the signalling cycle and different approximations to the active state. These active structures include the A 2A adenosine receptor bound to the (b) In the inactive rhodopsin structure (top), the photoaffinity group attached to cis-retinol interacts with Trp 265 (6.48) , an interaction that is fully compatible with the ground state structure, which has Ala 169(4.58) facing the lipid. The structure below shows the interaction between the trans-retinol and Ala 169(4.58) , which has been facilitated by a large conformational change in TM4. (c) A rhodopsin dimer (ribbons) involving an active receptor (left) containing trans-retinol (blue) and an inactive receptor (right) containing cis-retinol (cyan). Two copies of TM4 lie at the dimer interface; the two copies of Ala 169(4.58) are shown as van der Waals surfaces. The point to note is the proximity of the trans-retinol from the active receptor to Ala 169(4.58) of the inactive receptor in the other part of the dimer.
agonist UK-432097 [19] , the β 2 -AR (β 2 -adrenergic receptor) in complex with the G-protein [8] , the β 2 -AR in complex with a nanobody [20] and two rhodopsin active structures alone or in complex with a G-protein C-terminal peptide, namely the constitutively active rhodopsin E114Q mutant [9] and the fully active Meta-II (metarhodopsin II) structure [21] . Structures of their inactive counterparts are also available [22] [23] [24] [25] .
Before the active-state X-ray structures, there were multiple approaches to modelling GPCR activation. One early approach involved running molecular dynamics simulations of the GPCR in the presence of a bound agonist. This relies on the hypothesis that the agonist will drive the desired conformational change within the timescale of the simulations. However, Rosenbaum et al. [26] have shown from X-ray crystallography that agonist binding alone is insufficient to generate a true active state since their resulting structure (PDB code 3PDS) was similar to inactive structures at the cytoplasmic ends. They inferred that G-protein binding was required to stabilize the true active state. Moreover, they have shown using molecular dynamics simulations that agonist-bound active structures may revert to the inactive conformation within 30 μs in the absence of active restraints. The alternative molecular dynamics-based strategy employed here used distance information on the active state derived from biochemical and biophysical experiments as restraints in the molecular dynamics simulations to drive the receptor to the active state [15] .
TM4 dimerization and active-state modelling
One of the most interesting active restraints was derived from photoaffinity labelling experiments that used a modified retinol as shown in Figure 1(a) . In the inactive state, a covalent link formed, unexpectedly, to Trp 265(6.48) (numbers in parentheses refer to the Ballesteros-Weinstein genral numbering scheme) (Figure 1b) . However, in the active structure, the covalent link is to Ala 169(4.58) , which normally resides on the external lipid-facing region of TM4 (transmembrane helix 4), implying a large conformational change in TM4 (Figure 1b ) [27] . We now know from the active X-ray structures [9, [19] [20] [21] 26 ] that this inferred conformational change is incorrect. Nevertheless, in attempting to apply this restraint in a rhodopsin dimer in which the dimer interface comprised two copies of TM4 [1, 7, 28, 29] , we observed that the photoaffinity group moved during the molecular dynamics simulations to reside close to Ala 169(4.58) of the other monomer. We therefore conclude that the covalent link correctly observed by Borhan et al. [27] was most likely to TM4 of a neighbouring receptor; our model is shown in Figure 1(C) . We are not told the extent of formation of this link; nevertheless, the implications of this result are 5-fold. First, the conformation of TM4 does not change on activation in the way originally implied by these results. Secondly, this provides further evidence for the formation of GPCR dimers with TM4 at the interface. Thirdly, this indicates that TM4 may be more mobile than we had previously realized. Fourthly, because a ligand may protrude between the helices, this provides evidence that bivalent ligands [30] may indeed interact with two binding sites in two receptors. Finally, similar arguments suggest that a ligand may enter the helical bundle from the membrane. (We certainly note the clear entrance and exit routes in the crystal structures [23] [24] [25] .) As a consequence of this observation, the restraint to Ala 169(4.58) was omitted in the generation of the active-state model [15] .
Comparing implicit membrane and explicit membrane simulations
Before assessing the active model generated using implicit membrane models, we will compare two models of the class B CGRP (calcitonin gene-related peptide) receptor, one generated using implicit methods, as described elsewhere [15] with the alignment based on the methods of Vohra et al. [3] and the other generated using comparable explicit methods using the OPLS 2005 force field for the protein/lipid [31] ; CGRP models were inserted into a pre-equilibrated membrane consisting of 68 POPC (1-palmitoyl-2-oleoyl phosphatidylcholine) and 6203 water molecules.
The two aligned inactive CGRP models are shown in Supplementary Figure S1 (at http://www.biochemsoctrans. org/bst/040/bst0400394add.htm). As can be seen, the alignment is good, with an RMSD (root mean square deviation) of 1.8 Å (1 Å = 0.1 nm) over all Cα atoms, which may be comparable with that between two crystal forms of the same receptor (data for rhodopsin given below). The differences are largely in the hydrated loop regions and TM4 (as an external helix, TM4 is more mobile because it is less constrained by the other helices). Supplementary Figure S2 (at http://www.biochemsoctrans.org/bst/040/bst0400394add. htm) shows the enhanced sampling in the implicit model, as the Cα root mean square fluctuations are indeed higher over most of the structure apart from extracellular loop 1.
Assessing the active model

Overall assessment
A superposition of the β 2 -AR active model, the two active rhodopsin X-ray structures and the active β 2 -AR X-ray structures is shown in Figure 2 (a). Table 1 shows that the two active rhodopsin structures are similar to each other, with an RMSD of 0.3 Å . Similarly, the two active β 2 -AR structures have an RMSD of 1.0 Å . The differences between the rhodopsin and the β 2 -AR active structures is somewhat larger at 1.7 Å , and this is greater than the difference between the active β 2 -AR model and the active β 2 -AR X-ray structure, where the RMSD is 1.3 Å . Analysis of Figure 2 (a) and the RMSD data show that the active-state modelling has been successful. Nevertheless, the quality of the model varies throughout the structures, with the RMSD of individual residues ranging from 1.0 Å in the TM region to 7.2 Å in Table 1 The RMSD between selected active GPCR structures, evaluated over the invariant transmembrane region The invariant TM region is defined as that where corresponding residues have a similar environment, i.e. internal, external, buried, over a range of structures, namely those with PDB codes 1U19, 2RH1, 3CAP, 3DBQ, 3EML and 2VT4. For example residue 117 is external in all of these receptors and so is part of the invariant TM region. Met 115 is external in 2VT4 and 2RH1, but Leu/Tyr 115 is internal in the other receptors and so residue 115 is outside the invariant TM region. The full data on the invariant region are given in Supplementary Tables S1-S7 at http://www.biochemsoctrans.org/bst/040/bst0400394add.htm. The values for the 1F88 and 1GZM rhodopsin inactive structures and for the partially active opsin structure 3DQB are given for reference.
the loop regions. The large values in the loop regions are to be expected since the loops are highly mobile and are also more extensively involved in crystal packing than the TM regions and this can lead to similarly large RMSDs even between X-ray structures of the same receptor. Thus the RMSD between the 1F88 and 1GZM rhodopsin structures is 2.4 Å over all chain A Cα atoms, as determined by Superpose (http://wishart.biology.ualberta.ca/superpose/) [32] , primarily because differences in crystal packing have resulted in alternative loop conformations. The agreement shown in Figure 2 (a) between the active model and the active structures is particularly good for TM1-TM3. TM4 shows a slightly higher RMSD, partly because there were no active restraints to TM4 and partly because, as an external helix, it is more mobile than the other helices. The RMSDs relative to the inactive β 2 -AR 2RH1 structure [24] are given in Supplementary Figure S4 on a residue by residue basis. Supplementary Figures S3 and S4 (at http://www.biochemsoctrans.org/bst/040/bst0400394add. htm) show that the movements on activation are generally small for TM1-TM4 and the greatest for TM5 and TM6 (because TM5 and TM6 have to move out to allow the G-protein binding). In terms of the degree of movement on activation, our model generally follows that of the active β 2 -AR structure 3SN6 for TM1, TM2 and TM5 and the active rhodopsin structure (3PQR/2X72) for TM3, TM4, TM6 and TM7; this pattern may arise from our use of opsin as a starting template but the model has clearly acquired characteristics of the active β 2 -AR structure. The key motion, namely the opening of TM5 and TM6 is quite well reproduced. Thus the intercellular end of TM6 moves out from its position in the inactive structure by 7 Å [as determined using the Cα of Glu 268 (6.30) ]. This is smaller than the 15 and 12 Å movement in 3SN6 and 3POG (both β 2 -AR) respectively but similar to the 8 and 5 Å movement in 3PQR (rhodopsin) and 3QAK (adenosine) respectively.
The orthosteric binding site
Active models were published containing four agonists, namely adrenaline, isoprenaline, salmeterol and TA-2005 [15] , the latter being very similar to the agonist BI-167107 used in the X-ray structure determination of 3SN6 and 3P0G, as shown in Supplementary Figure S5 (at http://www.biochemsoctrans.org/bst/040/bst0400394add. htm). In total, these ligands bind to 38 distinct residues in the six structures. Eleven of these residues only interact with the tail region of salmeterol and just five are found only in the crystal X-ray structures. The RMSD between the active model and the 3NS6 structure over the residues of the orthosteric binding site is 1.3 Å . Most of the interactions in the catechol region are common between the two structures, including the interactions of the three serine residues (Ser 203 , Ser 204 and Ser 207 ). There are also conserved hydrogen-bond interactions to the NH 2 + link with residues Asp 113 and Asn 293 . There are differences in the 'tail' region (Supplementary Figure S6 at http://www. biochemsoctrans.org/bst/040/bst0400394add.htm), but this is to be expected as the ligands are different in this region. It is thus reasonable to claim that the orthosteric binding site has been well modelled, and this is probably the reason why the virtual screening results were good [15] . Indeed, many other studies have obtained good results for virtual screening against GPCR models.
Microswitches
DRY and NPXXY motifs
The most important microswitch is probably that involving the DRY motif at the intracellular end of TM3. In the inactive X-ray structure, Arg 
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It has been proposed that Trp 286(6.48) changes conformation from gauche minus in the inactive conformation to trans in the active conformation in the 'toggle switch' activation [33] [34] [35] [36] [37] [38] [39] [40] . This change is not observed in any of the active structures, as shown in Supplementary Figure S7 (a) at http://www.biochemsoctrans.org/bst/040/bst0400394add. htm. The implementation of a restraint based on the proposed rotamer toggle switch [15] is probably the reason for some of the discrepancies between our active model structure and the active X-ray crystal structures -nevertheless, no constraint was placed on ϕ 1 and so the aromatic ring remained parallel to the membrane normal as shown in Supplementary Figure S7(b) , rather than horizontal as proposed by many authors, e.g. [33] . The restricted movement of the rotamer toggle switch is surprising as the toggle switch hypothesis has been explicitly used to design agonists and antagonists with some success [35] . The reason for the apparent discrepancy, between the X-ray structures and the experimental information that lead to the rotamer toggle switch hypothesis, will be of much interest.
The G-protein-binding site
The key GPCR-G-protein interactions that were correctly predicted, as determined using the PISA software [41] , are shown in Figure 2 (b) as opaque, space-filled residues; the residues that were not correctly predicted are shown as transparent space-filled residues. Of the 38 receptor and 34 G-protein interface residues, 27 and 20, i.e. 71 and 59 % respectively were correctly predicted. The model is therefore by no means accurate at the atomic level but it does indicate most of the regions of the receptor and G-protein that interact.
The of rhodopsin interact through water-mediated hydrogenbonding with the Asn 343 , Cys 347 , Asp 346 of the C-terminal peptide respectively in the constitutively active rhodopsin structure; these water molecules are not visible in the Meta II or the opsin structures: such differences can greatly complicate modelling. Owing to the perceived difficulties of modelling such a complex, the structure was reported in Supplementary information of [15] rather than in the body of the text. Nevertheless, the GPCR:G-protein complex has been modelled well, despite the fact that it was refined using minimization rather than dynamics and minimization.
In conclusion, it appears that the model has been a very good surrogate for the active structure in that it is consistent with many of the active-state structures recently reported in the literature. It is a necessary consequence, however, of homology modelling that a number of molecular details seen in the single conformation X-ray structure were not reproduced. 
Molecular details of the GPCR-G-protein interaction β 2 -AR residues
The interaction interface on IL1 (intercellular loop 1) was over-predicted: the two interface residues in 3SN6 were correctly predicted along with seven other flanking residues. Seventy-one percent of the 14 IL2 interface residues were correctly predicted, with only four omitted and only four incorrectly predicted. Some 61 % of the 19 IL3 interface residues were correctly predicted, with seven omitted and an extra six incorrectly predicted, despite the fact that IL3 was truncated in our model. The conserved Val 5.61 was not predicted but the conserved Ala 5.65 was correctly predictedthese are highly conserved hydrophobic positions in class A and class B. The highly conserved Tyr 5.58 was correctly predicted not to interact, despite its proximity to the C-terminal peptide in the opsin structure. The three interface residues on helix eight were correctly predicted, along with eight additional flanking residues; the over-prediction was due to incorrect modelling of the highly flexible C-terminal region of TM7.
G-protein residues
With regard to interacting residues on the G-protein, five of the six interacting residues on the N-terminus (helix 1/strand 1, according to the PDB entry) were correctly predicted. The sole interacting residue (Pro 138 ) on the α-helical domain (helix 5) was predictably not identified, given the large conformational change in the α-helical domain [1, 3] . The two hydrophobic residues on strand 3 were not predicted. The residues (∼323-335) in/near helix 19 were not predicted, despite the orientation of TM5 and TM6 towards this region, because of the truncation in IL3. In contrast, the residues on/near strand 6 were over-predicted because of the loop at 1 To whom correspondence should be addressed (email reync@essex.ac.uk). of the receptor and Tyr 391 of the G-protein, even though the helix enters the receptor at a more vertical angle than in 3SN6 and is slightly rotated; as a consequence the four residues pointing away from the receptor were falsely predicted to interact. The structural alignment was carried out using the stamp [4] from within in visual molecular dynamics [2] . The explicit C-terminus was truncated at position 8.64, whereas the implicit C-terminus had 20 more residues and more structure, hence the small fluctuations over helix 8. The RMSD is shown for each residue in the sequence.
Figure S5
The structure of agonists TA2005 and BI-167107 Figure S6 The interaction between the active β 2 -AR and the agonists TA2005 (cyan) and BI-167107 (orange 30PG and purple 3SN6), as determined by modelling and X-ray crystallography respectively Table if they are non-helical for at least one receptor. A key to colours is shown beneath the Table. Single-letter codes are used for amino acids. Table. Single-letter codes are used for amino acids.
Table S3
The common helical region of TM3 generally runs from 312 to 343, but the main invariant region runs from 315 to 341 Grey in column 1 indicates the invariant helical region where all/most of the residues within this range are roughly in the same kind of environment. Grey in columns 2-9 indicate non-helical regions, as indicated by DSSP, etc. at the PDB (http://www.rcsb.org). Non-helical regions have been truncated from the beginning and end of the Table if they are non-helical for at least one receptor. A key to colours is shown beneath the Table. Single-letter codes are used for amino acids.
Table S4
The common helical region of TM4 generally runs from 410 to 427, but the main invariant region runs from 410 to 425 Grey in column 1 indicates the invariant helical region where all/most of the residues within this range are roughly in the same kind of environment. Grey in columns 2-9 indicate non-helical regions, as indicated by DSSP, etc. at the PDB (http://www.rcsb.org). Non-helical regions have been truncated from the beginning and end of the Table if they are non-helical for at least one receptor. A key to colours is shown beneath the Table. Single-letter codes are used for amino acids.
Table S5
The common helical region of TM5 generally runs from 506 to 529, but the main invariant region runs from 508 to 526 Note the helical irregularities, e.g. F180 and 3EML. Grey in column 1 indicates the invariant helical region where all/most of the residues within this range are roughly in the same kind of environment. Grey in columns 2-9 indicate non-helical regions, as indicated by DSSP, etc. at the PDB (http://www.rcsb.org). Non-helical regions have been truncated from the beginning and end of the Table if they are non-helical for at least one receptor. A key to colours is shown beneath the Table. Single-letter codes are used for amino acids.
Table S6
The common helical region of TM6 generally runs from 600 to 828, but the main invariant region runs from 605 to 621 Grey in column 1 indicates the invariant helical region where all/most of the residues within this range are roughly in the same kind of environment. Grey in columns 2-9 indicate non-helical regions, as indicated by DSSP, etc. at the PDB (http://www.rcsb.org). Non-helical regions have been truncated from the beginning and end of the Table if they are non-helical for at least one receptor. A key to colours is shown beneath the Table. Single-letter codes are used for amino acids.
